A new study (Cullen, 2018) suggests that I.V. Ascorbate "can act synergistically with pro-oxidant therapies - chemo and radiation - to enhance anti-tumor effect."
What did this team from University of Iowa find in their landmark study and published paper?
I.V. Ascorbate increased the toxic potency of radiation therapy to pancreatic cancer cells more than using radiation alone. Ascorbate acid plus radiation did less damage tp healthy jejunal cells less than radiation alone. Increasing an anti-tumor effect and protecting healthy cells is a win-win.
Radiation causes heavy damage to the mitochondria in small intestine's jejunal epithelial cells. Incorporating I.V. Ascorbate acid was able to partially inhibit mitochondrial damage as evidenced by less villous blunting, less loss of crypt cells and less loss of collagen deposition.
In a human study with I.V. Ascorbate acid, Ascorbate was administered during radiation therapy to determine safety, efficacy and dosages. Doses ranged from 50 grams to 75 grams and then up to 100 grams. Those who received I.V. Ascorbate-gemcitabine-radiation median overall survival rate was 21.7 months compared to chemo-radiation patients whose median overall survival rate was 12.7 months.
I.V. Ascorbate was proved to be safe in doses ranging from 50 grams up to 100 grams. Studies have shown that I.V. Ascorbate reduced side effects from standard chemo/radiation treatment. More patients in the standard treatment group were able to complete standard treatment. There were significant improvements to quality of life.
The findings of this recent study will encourage doctors and patients to incorporate I.V. Ascorbate Acid into treatment protocols. This is integrative cancer treatment at its best.
If you are doing standard chemo and radiation treatment, then you want to consider adding in I.V. Ascorbate therapy into your protocol. Call us to discuss your options. We are certified with The Greece test. A brilliant test to determine which therapies are responsive for your cancer.